GNH USA

Europe — EMA

Levodopa Plus Benserazid Al (Benserazide, Levodopa)

GNH USA supplies Levodopa Plus Benserazid Al (Levodopa/Benserazide), a antiparkinson agent for Parkinson's disease. Request a quote for global supply.

Benserazide, Levodopa

Request sourcing

1
Pack/s

What is Benserazide, Levodopa?

Levodopa, the active ingredient in Levodopa Plus Benserazid Al, is a Levodopa/benserazide combination presented as an oral tablet for oral use. Classified as an antiparkinson agent and marketed in the EU, it is used to improve motor function in adult patients with Parkinson's disease.

GNH USA supplies Levodopa Plus Benserazid Al as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide, ensuring quality and regulatory compliance for global distribution, including procurement teams in emerging markets and research institutions.

What is Benserazide, Levodopa used for?

Levodopa/benserazide acts on the dopaminergic pathway to manage Parkinsonian disorders. - Parkinson's disease: improves motor symptoms such as bradykinesia, rigidity and tremor. - Early-stage Parkinsonian syndrome: delays the onset of motor fluctuations. - Advanced Parkinson's disease with motor fluctuations: reduces "off" periods and enhances daily functioning.

What are the side effects of Benserazide, Levodopa?

Levodopa/benserazide may cause a range of adverse reactions.

Common Side Effects: - Nausea: mild to moderate gastrointestinal upset. - Dizziness: often related to orthostatic changes. - Headache: transient and usually resolves. - Insomnia: difficulty initiating sleep. - Orthostatic hypotension: drop in blood pressure upon standing. - Dry mouth: reduced salivation.

Serious or Rare Side Effects: - Dyskinesia: involuntary, erratic movements. - Hallucinations: visual or auditory disturbances. - Severe hypotension: may lead to fainting. - Cardiac arrhythmias: irregular heart rhythms. - Neuroleptic malignant syndrome: rare but life‑threatening reaction. - Anaphylaxis: acute allergic response requiring emergency care.

What precautions apply to Benserazide, Levodopa?

Levodopa/benserazide requires careful monitoring to ensure safe use. - Monitor blood pressure: watch for orthostatic drops, especially at treatment initiation. - Assess psychiatric status: be alert for hallucinations or confusion. - Adjust dose in renal impairment: reduced clearance may increase exposure. - Avoid abrupt discontinuation: taper gradually to prevent withdrawal symptoms. - Use with caution in elderly patients: increased sensitivity to side effects. - Store at ambient temperature: keep in original container, protect from moisture and direct sunlight.

What does Benserazide, Levodopa interact with?

Levodopa/benserazide can interact with several drug classes.

Major Interactions (Avoid): - Non‑selective MAO inhibitors: risk of hypertensive crisis. - Antipsychotics (dopamine antagonists): may diminish therapeutic effect. - High‑protein meals: can reduce levodopa absorption. - MAO‑B inhibitors: increase risk of serotonin syndrome.

Moderate Interactions (Monitor Closely): - Antihypertensive agents: additive blood‑pressure lowering. - SSRIs and SNRIs: potential for serotonin excess. - Other antiparkinson drugs: may require dose adjustments. - Alcohol: can exacerbate dizziness and hypotension.

Frequently asked questions

What is Levodopa Plus Benserazid Al used for?+
Levodopa Plus Benserazid Al is used to treat Parkinson's disease. It helps improve motor symptoms such as tremor, rigidity, and bradykinesia by restoring dopamine levels in the brain, thereby enhancing daily functional abilities in affected patients.
How does Levodopa work in the body?+
Levodopa is a precursor of dopamine that crosses the blood‑brain barrier and is converted into dopamine within the central nervous system. This increase in dopamine compensates for the loss of dopaminergic neurons characteristic of Parkinson's disease, improving motor control.
What is the usual dose of Levodopa Plus Benserazid Al?+
The appropriate dose of Levodopa Plus Benserazid Al is determined individually by a qualified prescriber based on the patient’s clinical condition, response to therapy, and tolerability. Dosage adjustments are made during treatment to achieve optimal symptom control.
Is Levodopa Plus Benserazid Al safe during pregnancy or breastfeeding?+
Safety data for Levodopa Plus Benserazid Al in pregnancy and lactation are limited. The medication should only be used if the potential benefit justifies the potential risk to the fetus or infant, and this decision must be made by a healthcare professional.
How do I order Levodopa Plus Benserazid Al from GNH USA?+
To place an order, submit an enquiry on the product page at gnh-usa.com specifying the required quantity. GNH USA works with hospitals, pharmacies, and procurement teams worldwide, verifies trade or institutional credentials, and then provides pricing, availability, shipping details, and any necessary import documentation.
How does Levodopa Plus Benserazid Al compare with other Parkinson’s medications?+
Levodopa combined with benserazide is considered the most effective symptomatic therapy for Parkinson’s disease, offering superior motor improvement compared with dopamine agonists or MAO‑B inhibitors. However, it may be associated with motor complications over long‑term use, which other drug classes aim to minimize.
What are the storage and handling requirements for this product?+
Levodopa Plus Benserazid Al should be stored at ambient temperature, below 25 °C, in its original packaging. Protect the tablets from moisture, heat, and direct sunlight to maintain potency throughout the shelf life.
How is Levodopa Plus Benserazid Al administered?+
The medication is taken orally, usually with a glass of water. It may be administered with or without food, but high‑protein meals can affect absorption, so patients are often advised to coordinate dosing with meals as directed by their prescriber.
What are the most serious risks associated with this therapy?+
Serious risks include the development of dyskinesias (involuntary movements), severe hypotension, hallucinations, and rare but life‑threatening conditions such as neuroleptic malignant syndrome or anaphylaxis. Patients should be monitored regularly for these adverse events.
Who should not use Levodopa Plus Benserazid Al?+
Patients with known hypersensitivity to levodopa, benserazide, or any excipients should avoid this medication. It is also contraindicated in individuals taking non‑selective MAO inhibitors and those with narrow‑angle glaucoma, unless specifically advised by a physician.
Information provided on this page is for educational use by procurement and clinical professionals. Always consult a licensed healthcare provider for medical advice and prescribing decisions. GNH USA supplies this product subject to applicable regulatory and licensing requirements.
Send a sourcing enquiry for this product →

Product details

Drug
Benserazide, Levodopa
Route
Oral Use
Manufacturer
Aliud Pharma Gmbh
Origin
EU

Related products

Levobens

Levobens

Benserazide, Levodopa

Teva Gmbh
EU
Levodopa Benserazid Beta

Levodopa Benserazid Beta

Benserazide, Levodopa

Betapharm Arzneimittel Gmbh
EU
Levodopa Benserazide Teva

Levodopa Benserazide Teva

Benserazide, Levodopa

Teva Santé
EU
Levodopa-Benserazid Teva

Levodopa-Benserazid Teva

Benserazide, Levodopa

Teva B.V
EU